← Open Payments lookup

WILLIAM WOODARD: Open Payments

NPI 1104345222 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,144 in 63 payments from 13 companies in 2025. Trend: 2023 $184 · 2024 $33 · 2025 $1,144

Food & beverage: $1,144
CompanyPaymentsAmount
Novo Nordisk Inc9$173
PFIZER INC.7$170
ABBVIE INC.12$154
AstraZeneca Pharmaceuticals LP9$150
Takeda Pharmaceuticals U.S.A., Inc.6$108
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$100
Otsuka America Pharmaceutical, Inc.2$64
Amgen Inc.3$55
Abbott Laboratories2$49
Axsome Therapeutics, Inc.2$41

Products named: AIRSUPRA, UBRELVY, TRINTELLIX, CAPLYTA, Ozempic, ELIQUIS, Wegovy, NURTEC ODT.

Industry payments across AL — which companies pay providers there.